Blood of My Blood across major markets across EMEA, LATAM, and APAC. SPT has finalized licensing agreements with MGM+ (U.K.), ...

PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

The new investment will support both organic and inorganic expansion, including growth in sterile fill-finish injectables, ...

The evaluation methodology utilized ToltIQ's proprietary platform architecture, enabling models to process large document sets representative of real-world due diligence scenarios. Performance was ...

Bain Capital’s bidding intentions for Perpetual are now known to be squarely focused on its wealth management unit and it ...

Private-equity firms Bain Capital and Kohlberg are leading a new multibillion-dollar investment in PCI Pharma Services, a company that specializes in helping biopharma companies bring new drugs to ...

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

Kohlberg and Mubadala, both of which initially invested in PCI in 2020, and Bain Capital are partnering with PCI's management team, led by Chief Executive Officer Salim Haffar, to accelerate the ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.

Fintel reports that on July 21, 2025, Truist Securities initiated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Buy ...